Replies to post #84676 on Amarin Corp Plc (AMRN)

[Benny7459]

Murphy,

Did you ask John (CEO) how company intends to pay for remainder of trial with current COH and scripts growing but not at rate to fund completion?

Benny

[centurycom]

He also said this March 05, 2015

" If the study is stopped based on overwhelming efficacy results, Amarin intends at that time to progress towards seeking approval for an expanded indication for Vascepa based on such results. Amarin is blinded to the results of the REDUCE-IT study and is planning for REDUCE-IT to continue until attainment of 100% of the 1,612 primary events which is estimated to be in 2017 with results anticipated to be published in 2018. "

Is this what he said to you?

Perhaps, this is why the company feels they will not need additional cash. The expanded indication could be Anchor. It is the only logical conclusion one could come to.

[irishpaddy]

Mr murphy

Lets us Irish stick together as the free speech across the big pond is very different to here in Ireland so for clarity
You stated that at the AGM
"CEO said NO STOP and that amrn and the fda want to to go to the end.He repeated again to me in person after the AGM"

So did the CEO state to all at the AGM that there will be no stop !!!! and did he repeat this to you in person at the end

You need to get this right as libel laws here are quiet onerous and there are several cases before the courts here on comments made via BBoards.

Dropping in lines like
"Im sure that's the line he used." sounds like you are very very definite that you are repeating exactly what was said in your last 4 posts here re the CEO's comments

So clarify